ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia

Por F. Noël, J.B. Nascimento-Viana, L.A.S. Romeiro, R.O. Silva, L.F.N. Lemes, A.S. Oliveira, T.B.S. Giorno, P.D. Fernandes, C.L.M. Silva